Review
[Progress in researches on anti-tumor agent L-asparaginase for treatment of leukemia]
[Article in
Chinese]
Affiliations
- PMID: 11285852
Item in Clipboard
Review
[Progress in researches on anti-tumor agent L-asparaginase for treatment of leukemia]
[Article in
Chinese]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi.
2000 Sep.
Abstract
L-asparaginase is a very effective anti-tumor agent. To take the most advantage of enzyme treatment method, the natural L-asparaginase could be chemically modified, entrapped or immobilized into/onto other carriers. The extracorporeal shunt system with immobilized enzyme reactor deserves to receive special attention. It provides an entirely new idea for leukemia treatment and is proved to be very prospective in the future leukemia cure.
Similar articles
-
A new extracorporeal reactor-dialyzer for enzyme therapy using immobilized L-asparaginase.J Pharmacol Exp Ther. 1979 May;209(2):271-4. J Pharmacol Exp Ther. 1979. PMID: 439002
-
[Progress in researches on L-asparaginase targeted to childhood leukemia].Zhonghua Er Ke Za Zhi. 2004 Mar;42(3):227-30. Zhonghua Er Ke Za Zhi. 2004. PMID: 15144726 Review. Chinese. No abstract available.
-
Monolith and coating enzymatic microreactors of L-asparaginase: kinetics study by MCE-LIF for potential application in acute lymphoblastic leukemia (ALL) treatment.Analyst. 2011 May 21;136(10):2077-83. doi: 10.1039/c1an15067g. Epub 2011 Apr 1. Analyst. 2011. PMID: 21461410
-
Antitumor enzyme: polyethylene glycol-modified asparaginase.Ann N Y Acad Sci. 1990;613:95-108. doi: 10.1111/j.1749-6632.1990.tb18151.x. Ann N Y Acad Sci. 1990. PMID: 2076022 Review. No abstract available.
-
A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.Cancer. 2003 Jan 15;97(2):508-16. doi: 10.1002/cncr.11042. Cancer. 2003. PMID: 12518376 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical